Literature DB >> 7441289

Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.

S Conradi, L O Ronnevi, G Nise, O Vesterberg.   

Abstract

The lead concentration in CSF was determined by flameless atomic absorption spectrophotometry in 16 ALS patients and 22 control cases. The mean values were 0.69 +/- 0.55 (ALS) and 0.41 +/- 0.37 (controls), P < 0.01. This confirms our earlier findings of raised CSF lead levels in ALS but the present values are lower than previously reported for both ALS patients and controls.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7441289     DOI： 10.1016/0022-510x(80)90112-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Motor neuron disease: etiology, pathogenesis and treatment--a review.

Authors:  D J Donohoe; B Brady
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

Review 2.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

3.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Authors:  Raffaella Uccelli; Alessandra Binazzi; Pierluigi Altavista; Stefano Belli; Pietro Comba; Marina Mastrantonio; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2007-09-14       Impact factor: 8.082

4.  High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid.

Authors:  W I Manton; J D Cook
Journal:  Br J Ind Med       Date:  1984-08

5.  Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

6.  Epidermal growth factor in human cerebrospinal fluid: reduced levels in amyotrophic lateral sclerosis.

Authors:  D Cieślak; J Szulc-Kuberska; H Stepień; A Klimek
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

Review 7.  Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms.

Authors:  H A El-Fawal; S J Waterman; A De Feo; M Y Shamy
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

Review 8.  Understanding the human health effects of chemical mixtures.

Authors:  David O Carpenter; Kathleen Arcaro; David C Spink
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

Review 9.  A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis.

Authors:  Ming-Dong Wang; James Gomes; Neil R Cashman; Julian Little; Daniel Krewski
Journal:  J Occup Environ Med       Date:  2014-12       Impact factor: 2.162

Review 10.  Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Cristiano Farace; Giovanni Fiorito; Giuliana Solinas; Roberto Madeddu; Andrea Pisano; Federica Etzi; Angela Sabalic; Grazia Fenu; Yolande Asara
Journal:  Neurol Sci       Date:  2022-07-09       Impact factor: 3.830
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.